Notice of Correction Regarding Companion Funding Opportunity Information for PAR-14-288 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)"
Notice Number:
NOT-NS-15-005
Key Dates
Release Date: December 8, 2014
Related Announcements
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
This Notice clarifies information regarding the companion funding opportunities to PAR-14-288 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)".
Part 1. Overview Information
The FOA currently reads:
Companion Funding Opportunity |
PAR-14-286, U01 Research Project – Cooperative Agreements PAR-14-287, U44 Small Business Innovation Research (SBIR) Cooperative Agreement – Fast-Track PAR-14-289, U44 Small Business Innovation Research (SBIR) Cooperative Agreement – Fast-Track |
The FOA is modified to read:
Companion Funding Opportunity |
PAR-14-286, U01 Research Project – Cooperative Agreements PAR-14-287, U44 Small Business Innovation Research (SBIR) Cooperative Agreement – Phase II, and Fast-Track PAR-14-289, U44 Small Business Innovation Research (SBIR) Cooperative Agreement – Fast-Track |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Hao Wang, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]
